Paragon Care Limited · ASX:PGC

Paragon Care — Investor Presentation (February 2026)

15 slides from Paragon Care's investor presentation, Feb 25, 2026

  1. Slide 1: Half Year Results Investor Presentation FY26

    Half Year Results Investor Presentation FY26 • ParagonCare Limited - ASX PGC

  2. Slide 2: Disclaimer

    Disclaimer This document has been prepared by Paragon Care Limited ACN 064 551 426 (ASX: PGC) (ParagonCare or the Company) (Presentation). The material in this Presentation contains general background information about ParagonCare and its current activities as at the date of this Presentation. The i

  3. Slide 3: Acknowledgement of Country and Traditional Owners

    Acknowledgement of Country and Traditional Owners ParagonCare acknowledges the Traditional Owners of the country in which our headquarters are located, in Australia. We recognise the continuing connection to lands, waters and communities and pay our respects to Aboriginal and Torres Strait Islander

  4. Slide 4: Presenters

    Carmen Riley Brendon Pentland Chief Executive Officer Chief Financial Officer Presenters ParagonCare - FY26 Half Year Results

  5. Slide 5: 1HFY26 Results

    1HFY26 Results 1HFY26 Underlying* Revenue EBITDA Net Profit After Tax $1.9+ billion $49.0^ million $13.3 million Up +2.9% on pcp Up +3.1% on pcp Up +0.7% on pcp 1HFY26 Statutory Revenue EBITDA Net Loss After Tax $1.9+ billion $(0.4) million $(21.3) million Up +2.9% on pcp Down (101)% on pcp Down (26

  6. Slide 6: Statutory to Underlying EBITDA Reconciliation

    Statutory to Underlying EBITDA Reconciliation $M HY26 HY25 Statutory EBITDA (0.4) 47.5 Adjusted for items identified as excluded from underlying earnings: Infinity Group debt provision, net of GST recoverable+ 46.4 - Mergers & acquisitions and related costs^ 2.0 - Restructuring & integration costs*

  7. Slide 7: 1HFY26 P&L

    1HFY26 P&L Underlying Result - $m HY26 HY25 Var % Revenue 1,904.9 1,850.4 2.9% Commentary EBITDA 49.0 47.5 3.1% Depreciation & Amortisation 15.3 15.3 - Revenue EBIT 33.7 32.2 4.5% • Group revenue growth, before normalisations (refer Revenue Bridge Finance Costs 15.6 15.3 1.9% slide), was 2.9% Profit

  8. Slide 8: 1HFY26 P&L

    1HFY26 P&L Commentary Underlying Result - $m HY26 HY25 Var % Revenue 1,904.9 1,850.4 2.9% Expenses EBITDA 49.0 47.5 3.1% • Expenditure included one-off expense for the Infinity Group debt Depreciation & Amortisation 15.3 15.3 - provision, integration costs and M&A activity EBIT 33.7 32.2 4.5% Financ

  9. Slide 9: Revenue Bridge – 1HFY26 v. 1HFY25

    1HFY26 P&L Revenue Bridge – 1HFY26 v. 1HFY25 evenue ridge , . . . , . . . . , . , . Normalised Revenue • Group revenue growth, before normalisations (Infinity , . Group sales & Covid-19 drugs), was 2.9% v. pcp , . • Adjusted for normalisations, Group revenue growth was , . 10.5% v. pcp • Organic rev

  10. Slide 10: Australia and New Zealand Overview

    Australia and New Zealand Overview ANZ Revenue & Margin by Channel Solid normalised revenue growth at a steady margin: Revenue $M HY26 HY25 Var $ Var % • ANZ revenue growth 2.1% before normalisations Wholesale 1,500.0 1,540.8 (40.8) (2.6)% • After adjusting for normalisations, revenue growth was +9.

  11. Slide 11: Asia Overview

    Asia Overview Strong revenue growth at healthy margin: Revenue $M HY26 HY25 Var $ Var % • Asia revenue growth 33.2% driven by the Aesthetics business Medical Technology 69.5 52.2 17.3 33.2% which benefited from new product sales and increased marketing investment Asia Total Revenue 69.5 52.2 17.3 33

  12. Slide 12: Statutory Balance Sheet

    1HFY26 Balance Sheet Statutory Commentary $m HY26 FY25^ Var % • Net working capital (NWC) movement reflects a combination of Receivables 406.5 401.5 1.2% business seasonality (inventory build leading up to and over the Inventory 295.0 282.5 4.4% end of calendar holiday period) and business acquisiti

  13. Slide 13: Statutory Cash Flow

    1HFY26 Cash Flow Statutory Commentary $m HY26 FY25 Var % • Improvement in cash flow from operations resulting from working Cash flows from operations (4.8) (19.5) 75.4% capital management focus Net interest paid (15.5) (14.5) (7.5)% • Net capital expenditure includes investment in new site at Willaw

  14. Slide 14: FY26 Outlook

    FY26 Outlook PGC confirms previously announced full year FY26 revenue and earnings guidance – • Revenue $3.6 - $3.7 billion • Underlying EBITDA - $97 - $107 million • Net debt / Underlying EBITDA (proforma^) – c. 2.0x (before any further acquisitions) Infinity Group debt totaling $48.5 million (inc.

  15. Slide 15: Thank you

    Thank you

Paragon Care — Investor Presentation (February 2026) on 6ix